These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22920637)

  • 41. Pivotal role of apoptosis signal-regulating kinase 1 in monoclonal free light chain-mediated apoptosis.
    Ying WZ; Wang PX; Sanders PW
    Am J Pathol; 2012 Jan; 180(1):41-7. PubMed ID: 22079929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracorporeal treatment of cast nephropathy.
    Gakhar B; Kobrin S; Berns JS
    Semin Dial; 2011; 24(1):9-11. PubMed ID: 21324000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.
    Menè P; Giammarioli E; Fofi C; Antolino G; Verde G; Tafuri A; Punzo G; Festuccia F
    Kidney Blood Press Res; 2018; 43(4):1263-1272. PubMed ID: 30078004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p66SHC-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury.
    Arany I; Faisal A; Clark JS; Vera T; Baliga R; Nagamine Y
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1214-21. PubMed ID: 20053790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel approaches for reducing free light chains in patients with myeloma kidney.
    Hutchison CA; Bladé J; Cockwell P; Cook M; Drayson M; Fermand JP; Kastritis E; Kyle R; Leung N; Pasquali S; Winearls C;
    Nat Rev Nephrol; 2012 Feb; 8(4):234-43. PubMed ID: 22349488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
    Granger Vallée A; Chenine L; Leray-Moragues H; Patrier L; Cognot C; Cartron G; Cristol JP; Canaud B
    Nephrol Dial Transplant; 2011 Nov; 26(11):3627-33. PubMed ID: 21508098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
    Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
    Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific impairment of proximal tubular cell proliferation by a monoclonal κ light chain responsible for Fanconi syndrome.
    El Hamel C; Aldigier JC; Oblet C; Laffleur B; Bridoux F; Cogné M
    Nephrol Dial Transplant; 2012 Dec; 27(12):4368-77. PubMed ID: 23024220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Light chain-mediated tubulopathies.
    Sanders PW
    Contrib Nephrol; 2011; 169():262-269. PubMed ID: 21252525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free light chains injure proximal tubule cells through the STAT1/HMGB1/TLR axis.
    Upadhyay R; Ying WZ; Nasrin Z; Safah H; Jaimes EA; Feng W; Sanders PW; Batuman V
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paraproteinemic renal diseases that involve the tubulo-interstitium.
    Herrera GA; Sanders PW
    Contrib Nephrol; 2007; 153():105-15. PubMed ID: 17075226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating myeloma cast nephropathy without treating myeloma.
    Leung N
    J Clin Invest; 2012 May; 122(5):1605-8. PubMed ID: 22484811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoglobulin light chains generate proinflammatory and profibrotic kidney injury.
    Ying WZ; Li X; Rangarajan S; Feng W; Curtis LM; Sanders PW
    J Clin Invest; 2019 Jun; 129(7):2792-2806. PubMed ID: 31205024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current approach to diagnosis and management of acute renal failure in myeloma patients.
    Leung N; Behrens J
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):297-302. PubMed ID: 22920640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Light chain proximal tubulopathy without crystals in a case of Burkitt lymphoma presenting with acute kidney injury.
    Rane S; Rana S; Sachdeva M; Joshi K
    Am J Kidney Dis; 2013 Sep; 62(3):638-41. PubMed ID: 23523237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of free light chain removal by four blood purification methods.
    Kanayama K; Ohashi A; Hasegawa M; Kondo F; Yamamoto Y; Sasaki M; Hayashi H; Kato M; Hattori R; Yamashita H; Arai J; Ishii J; Emi N; Yuzawa Y
    Ther Apher Dial; 2011 Aug; 15(4):394-9. PubMed ID: 21884475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains.
    Melcion C; Mougenot B; Baudouin B; Ronco P; Moulonguet-Doleris L; Vanhille P; Beaufils M; Morel-Maroger L; Verroust P; Richet G
    Clin Nephrol; 1984 Sep; 22(3):138-43. PubMed ID: 6435919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Biochemical and immunological findings of multiple myeloma].
    Asaoku H
    Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The double polymethylmethacrylate filter (DELETE system) in the removal of light chains in chronic dialysis patients with multiple myeloma.
    Santoro A; Grazia M; Mancini E
    Blood Purif; 2013; 35 Suppl 2():5-13. PubMed ID: 23676829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.